Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...

Under Operation Warp Speed, the government could incentivize private companies with $10 billion of funding that had been allocated for vaccine development. In less than a year, vaccines for COVID ...

Under Operation Warp Speed, the government could incentivize private companies with $10 billion of funding that had been allocated for vaccine development. In less than a year, vaccines for COVID ...

He gets a hefty portion of credit for Trump’s Operation Warp Speed, the effort to turbocharge the development of COVID vaccines, and he came up with the moniker. His center also regulates gene ...

During his tenure, he was responsible for approving 22 gene therapies and played a major role in Operation Warp Speed, the initiative that accelerated the development of the COVID-19 vaccine.

He was a key part of Operation Warp Speed during the COVID-19 pandemic in the first Trump administration and became a member of the National Academy of Medicine in 2022. The longtime FDA official ...

Dr. Marks, a key figure in orchestrating Operation Warp Speed beginning in March 2020, played the central role in the development and deployment of COVID-19 vaccines within a year of the pandemic ...

He helped lead the fast-tracked development and approval of COVID vaccines and created the name and idea behind "Operation Warp Speed" -- which helped get vaccines to people in record time.

The Wall Street Journal reported Friday that Dr. Peter Marks, who played a critical role in the first Trump administration's Operation Warp Speed to develop Covid-19 vaccines, stepped down after ...

He led regulatory efforts for the Covid vaccine during the pandemic. Operation Warp Speed was his legacy. The resignation further reaffirms that drug stocks, especially those in the vaccine market ...

Dr Peter Marks, who has worked at the Food and Drug Administration (FDA) since 2012, cited the “concerning” vaccine efforts of the Trump administration in the letter, published by The ...

Peter Marks, who was a key figure in Operation Warp Speed, stepped down from his position as the director of the FDA’s Center for Biologics Evaluation and Research, which is responsible for the ...